Search for content, post, videos

Boehringer Ingelheim signs license deal with Qlucore

Carl-Johan Ivarsson

Boehringer Ingelheim has ordered licenses from Qlucore at a value of approximately 142,000 EUR for the use of Qlucore Omics Explorer for two years.

Boehringer Ingelheim is an existing Qlucore customer, and this license is for global use of Qlucore’s software. Qlucore Omics Explorer is software for research applications within the pharma, biotech and academic communities. The user is provided with functionality including fast, interactive visualization combined with smart calculations to discover important information and findings in large, and often extremely large, data sets.

“We are delighted that Boehringer Ingelheim has again decided to order Qlucore Omics Explorer licenses from us for use in its research and development,” says Carl-Johan Ivarsson, Qlucore CEO.

Photo of Carl-Johan Ivarsson: Qlucore